Webinar
26
Sep
2023
2023
18
00
CEST
CEST
Evidence standards for conditional approval of targeted therapies
Starting from the major outcomes of the “Improving Efficiency in Cancer Care: 2020-2021” project, held in collaboration with All.Can and SDA Bocconi School of Management, the SPCC - All.Can Project: Data Driven Cancer Care for Better Outcomes will focus on the essential role of Data in Cancer Care to improve outcomes across the Cancer Care Continuum (from screening to diagnosis, from treatment and care to follow-up and survivorship).
The webinars will be subtitled in 25 different languages.
Speakers
Discussant
Pignatti Francesco
Head of Oncology, Haematology, Diagnostics - Safety and Efficacy Sector - European Medicines Agency (EMA), Amsterdam, The Netherlands
Expert
de Claro R. Angelo
Associate Director for Global Clinical Sciences, FDA Oncology Center of Excellence; Division Director, Division of Hematologic Malignancies I at FDA, Silver Spring, USA
Expert
Postmus Douwe
Assistant professor, Department of Epidemiology, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands
This material is part of Educational
Project:
2023 - SPCC and All.Can Project: Data Driven Cancer Care for Better Outcomes